Controls pain in procedures involving the male and female urethra for topical treatment…. ANDA 86283, held by Intl Medication. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 86283 (Lidocaine Hydrochloride), held by Intl Medication, was first approved by FDA on Aug 7, 1979, with 11 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE: Lidocaine Hydrochloride Jelly USP, 2% is indicated for prevention and control of pain in procedures involving the male and female urethra for topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation (oral and nasal).
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 7, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lidocaine Hydrochloride2% · jelly;topical | Lidocaine Hydrochloride | Rx |
| Aug 22, 2025 | Supplement 29Labeling · Standard review | Approved | None posted |
| Aug 22, 2025 | Supplement 30Labeling · Standard review | Approved | None posted |
| Sep 19, 1995 | Supplement 16Manufacturing | Approved | None posted |
| Jun 17, 1994 | Supplement 15Manufacturing | Approved | None posted |
| Aug 25, 1993 | Supplement 14Labeling | Approved | None posted |
| Feb 8, 1993 | Supplement 11Manufacturing | Approved | None posted |
| Dec 17, 1992 | Supplement 13Manufacturing | Approved | None posted |
| Jul 10, 1987 | Supplement 7Manufacturing | Approved | None posted |
| Mar 5, 1987 | Supplement 5Manufacturing | Approved | None posted |
| May 16, 1986 | Supplement 2Manufacturing | Approved | None posted |
| May 16, 1986 | Supplement 3Manufacturing | Approved | None posted |
| Aug 7, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters